The bench to bedside journey of drugs is fraught with challenges. It is estimated that only 5 in 5,000 compounds that enter preclinical testing make it to human testing, and out of those 5, only 1 may pass through all the regulatory hurdles needed to reach pharmacy shelves.
from RTT - Biotech http://ift.tt/1Wzvaf4
via IFTTT
No comments:
Post a Comment